David Chichester
Analyst · Oppenheimer
Thank you, John. Good afternoon, everybody. Earlier today we issued our press release. Over the next few minutes, I'll provide some financial highlights, starting with an overview of the year, before moving to the quarterly results. As John indicated, our company reported a robust increase in earnings per share for the year, up 124% on an adjusted basis to $0.74 per share. For comparability purposes, I will be using adjusted figures on all, except when I indicate otherwise. The adjusted numbers take into account the effects of a $7.3 million non-cash intangibles impairment charge in our Pet segment in the fourth quarter 2015 as well as a $16.9 million charge for the discontinuance of Garden products in 2014. Also in 2014, there was a $4.9 million gain on sale of Garden plant fixed assets, $2.9 million of which occurred in 2014 fourth quarter. Consolidated sales for the full year increased 2% versus the prior year. Our consolidated gross profit rose 4%, and our 2015 gross margin increased 40 basis points to 29.6%. SG&A expense for the year declined 3% or $13 million versus a year ago, and as a percent of sales declined to 23.6% from 25% in the prior year. Operating income for the fiscal year rose nearly $99 million. A strong gain of 45% or $30.5 million compared to 2014. Our operating margin is 6% and was up from 4.2%. We're delighted with the progress made in increasing our operating profit and margin. For the full year, Pet segment sales increased 6% or nearly $50 million to $894 million. On the strength of increased dog and cat and professional revenues as well as higher sales of other manufactured products. Pet segment operating income increased $18 million or 20% compared to the prior year and operating margin rose 150 basis points to 11.9%. Higher sales and lower SG&A expenses increased both net operating income and margin. Our dog and cat, flea and tick and professional businesses drove the increase in operating profit margin. For the year, Garden segment sales were down 1% or $9.7 million, attributable primarily to a drop in grass seed and decor revenues. Despite the sales decline, Garden operating income rose 13% to slightly over $60 million, its second most profitable year ever, and operating margin increased a healthy 110 basis points to 8%. The gains in both operating profit and margin were driven by higher controls and fertilizer sales. And higher gross margin in those businesses, due to a favorable product mix as well as lower SG&A expenses. Moving to the fourth quarter results. Although, the fourth quarter has been a loss quarter for Central in recent years, we are very pleased that adjusted earnings turned positive this year. Staying at the topline, consolidated sales for the quarter is 3% over fourth quarter 2014, on strength of net sales. Gross profit dollars were relatively flat compared to the prior-year period, while gross margin declined 80 basis points to 27.9%. Both are Garden and Pet segments contributed to the decrease. SG&A expense as a percentage of sales declined significantly by 340 basis points, due in part to the decline in corporate expenses, principally the non-recurrence of $5.9 million of software costs in the prior-year period. Operating income rose by over $10 million to $8.6 million compared to an operating loss of $1.5 million in 2014 fourth quarter. Operating margin improved to 2.2% compared to a negative operating margin in the fourth quarter of last year. Now, I'd like to give you some color on the quarterly results by segment. Pet revenues grew 9% versus the fourth quarter of 2014, on strength in most of the pet categories. Dog and cat was the fastest growing category, benefiting from two months of sales from our IMS acquisition as well as higher revenue in our Nylabone business. Higher professional businesses or the natural higher professional revenues in the natural insecticide business and the livestock production business contributed to the increase. Also, our Pet distribution business, which as you know distributes products manufactured by other companies, achieved higher sales, benefited from expanded relationship with a food, drug and mass customer and increased sales e-commerce channel. Pet operating income for the quarter increased 21% to $25.5 million compared to $21.1 million a year ago and margin increased 110 basis points to 10.8%. Both benefited from higher sales and lower SG&A expenses in our flea and tick, small animal and dog and cat business. Partially offsetting those gains was lower profitability in our aquatics and equine. Garden segment sales for fourth quarter declined 4% versus the same period a year ago, due primarily to a decline in grass seed sales, which continues the weakness experienced in that category over the course of the year. Less weather-related lawn damage, the timing of sales to a major retailer and to a lesser extent lower export sales through a stronger dollar were factors in the sales reduction. Decor sales were down this quarter due to the lower promotional spending on favorable products. Higher wild bird feed revenues and higher sales of other manufactured products offset some of these weaknesses. Garden operating income for the quarter was about $1 million compared to $3.6 million in the fourth quarter of last year. Operating margin declined 0.6% compared to an adjusted 2.3%. The chief cause of the decline in operating income and margin was lower profitability in the decor category, which we are now resetting in 2016. This category is impacted by lower volume and unfavorable product mix, inventory reduction and unanticipated rework costs. Partially offsetting decor weakness were higher operating margins in our grass seed and wild bird feed businesses. Moving back to our consolidated results for the quarter. Net interest expense decreased $1.1 million from the prior year to $8.6 million, primarily due to lower average borrowings, including impact of the redemption of $50 million of our 8.25% senior subordinated notes in the second quarter. Our adjusted net income was $285,000 and diluted earning per shares were $0.01 comparing favorably to an adjusted loss of $5.9 million or $0.12 a share for the fourth quarter of 2014. I'll wrap up with a quick review of our cash flow and balance sheet. By the way, these are all GAAP numbers. For the full year, cash flow from operations was $87 million. Fourth quarter operating cash flow was $31 million. The company's inventory balance rose by $9.6 million from year ago to support increasing sales of existing products and the IMS acquisition. Full year 2015 capital spending was [ph] $22 million, modestly below our historical annual run rate of $25 million. We would expect 2016 to be somewhat above historical levels, as we build capacity in businesses that are experiencing a high level of demand and as we continue our low-cost producer. CapEx for the quarter was nearly $4 million versus $3.5 million in the fourth quarter of last year. Depreciation and amortization for the year was $33.7 million, down from $35.8 million a year ago. Our debt declined $50 million to $400 million and significantly improved our financial flexibility. As per the bank credit facility calculation, our leverage ratio at yearend declined 2.8x, down 4.4x. At the end of the year, there were no borrowings outstanding under the credit facility, with $384 million of availability. In fact, for the majority of the year we had no credit facility borrowings. Interest expense for the year totaled nearly $40 million, down from nearly $43 million in 2014. In early November, we refinanced $400 million of the 8.25% coupon notes at a very attractive 6.125% offering of eight-year note, saving 2.125%, cutting $8.5 million of annual interest expense. The issuance of our new notes and the redemption of the old notes will result in the first quarter charge to interest expense of approximately $8.3 million related to the bulk, and a $3.2 million non-cash charge for the write-off of unamortized financing costs. Additionally, we've had an overlap of one month of interest expense from the old and new notes, around a $2.8 million impact. In total, we expect a $14.3 million charge for these three one-time items in the first quarter fiscal 2016. During the quarter, we did not repurchase any of our outstanding stock and approximately $35 million remains available under the Board approved stock repurchase. Now, I'll turn it back over to John, to provide some perspective on the year ahead.